International Stem Cell Corporation announced that on February 1, 2022, Sophia Garnette, Principal Financial Officer and VP of Legal Affairs and Operations of International Stem Cell Corporation, submitted her resignation, to be effective on April 1, 2022. The Company is evaluating alternatives for persons to serve as principal financial officer following Ms. Garnette's departure. Ms. Garnette has advised the Company that she will be available to assist with any transition once her successor has been identified by the Company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1134 USD | +117.66% | +117.66% | +82.90% |
1st Jan change | Capi. | |
---|---|---|
+82.90% | 908K | |
+17.09% | 45.34B | |
+42.10% | 40.42B | |
-9.70% | 37.92B | |
+33.28% | 31.75B | |
-8.98% | 27.71B | |
+13.37% | 26.52B | |
+44.11% | 13.96B | |
+32.33% | 12.44B | |
-7.26% | 11.26B |
- Stock Market
- Equities
- ISCO Stock
- News International Stem Cell Corporation
- International Stem Cell Corporation Announces Resignation of Sophia Garnette as Principal Financial Officer and VP of Legal Affairs and Operations, Effective April 1, 2022